Advocacy intelligence hub — real-time data for patient organizations
Taipei Veterans General Hospital, Taiwan — NA
Kriya Therapeutics, Inc. — PHASE1, PHASE2
Shanghai Changzheng Hospital — PHASE4
Sun Yat-sen University — NA
Sling Therapeutics, Inc. — PHASE2, PHASE3
Althaia Xarxa Assistencial Universitària de Manresa — NA
Sanofi — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Laurent Servais, MD
Centre Hospitalier Universitaire de Liege
Ignatia B Van den Veyver, MD
Baylor College of Medicine
Michael D Straiko, M.D., M.D
Devers Eye Institute
📍 PORTLAND, OR
Robert Casson, MBBS (Hons)
Royal Adelaide Hospital
Doron Hickey, MBChB
The Centre for Eye Research Australia (CERA)
Isabelle Audo, Pr
Centre National d'Ophtalmologie des Quinze-Vingts
View all Genetic developmental defect of the eye specialists →